Merz Pharma Group to Complete Acquisition of BioForm Medical, Inc.  
2/19/2010 9:54:05 AM

FRANKFURT & SAN MATEO, Calif.--(BUSINESS WIRE)--Merz Pharma Group announced today that the subsequent offering period of the tender offer by Merz GmbH & Co. KGaA (“Merz”) and its acquisition subsidiary to purchase all of the outstanding shares of common stock of BioForm Medical, Inc. (Nasdaq: BFRM) at a price of $5.45 per share, net to the seller in cash (without interest thereon and less any required withholding tax) expired as scheduled at 12:00 midnight, Eastern Standard Time, on February 18, 2010.